Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ACELRX PHARMACEUTICALS, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-09-20 to 2022-09-24
Current total value of award: $935237.2
Description: DE-OBLIGATE EXCESS FUNDS